Melanoma Relapse can be Reduced by Immune Therapy

Patients with high-risk melanoma who had a course of pembrolizumab after their surgery had a longer time before their disease recurred than patients who got either ipilimumab or high-dose interferon after surgery.

Related Keywords

,Cancer Research Network ,Research Network ,Melanoma ,High Risk Melanoma ,Pembrolizumab ,Surgery ,Ipilimumab ,Igh Dose Interferon ,புற்றுநோய் ஆராய்ச்சி வலைப்பின்னல் ,ஆராய்ச்சி வலைப்பின்னல் ,மெலனோமா ,